Simulations Plus (NASDAQ:SLP) Now Covered by Stephens

Stephens began coverage on shares of Simulations Plus (NASDAQ:SLP) in a report issued on Friday morning, MarketBeat.com reports. The brokerage issued an overweight rating and a $39.00 target price on the technology company’s stock.

Several other equities research analysts have also issued reports on SLP. BTIG Research lowered their price target on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research note on Thursday, October 24th. StockNews.com downgraded Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. William Blair reissued an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, November 6th. Finally, KeyCorp initiated coverage on Simulations Plus in a research note on Monday, July 29th. They issued an “overweight” rating and a $47.00 price target for the company. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Simulations Plus currently has an average rating of “Moderate Buy” and a consensus target price of $51.40.

Simulations Plus Price Performance

SLP stock opened at $28.29 on Friday. The stock has a market capitalization of $567.78 million, a P/E ratio of 59.23 and a beta of 0.71. Simulations Plus has a fifty-two week low of $27.22 and a fifty-two week high of $51.22. The business has a 50-day moving average of $31.19 and a 200-day moving average of $38.83.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The firm had revenue of $18.70 million during the quarter, compared to the consensus estimate of $19.73 million. During the same quarter in the prior year, the firm posted $0.18 EPS. The business’s revenue was up 19.9% on a year-over-year basis. Equities analysts expect that Simulations Plus will post 1.12 EPS for the current year.

Insiders Place Their Bets

In other news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $35.18, for a total transaction of $703,600.00. Following the completion of the sale, the director now owns 3,501,592 shares in the company, valued at approximately $123,186,006.56. This trade represents a 0.57 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders have sold a total of 60,750 shares of company stock valued at $1,905,655 over the last 90 days. 20.90% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Geode Capital Management LLC increased its position in Simulations Plus by 4.4% during the 3rd quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company’s stock worth $14,367,000 after buying an additional 18,924 shares during the period. Barclays PLC increased its position in Simulations Plus by 390.6% during the third quarter. Barclays PLC now owns 28,473 shares of the technology company’s stock worth $911,000 after acquiring an additional 22,669 shares during the period. First National Bank of Omaha raised its stake in Simulations Plus by 56.1% in the 3rd quarter. First National Bank of Omaha now owns 9,704 shares of the technology company’s stock worth $311,000 after purchasing an additional 3,488 shares in the last quarter. State Street Corp boosted its holdings in Simulations Plus by 4.7% in the 3rd quarter. State Street Corp now owns 640,303 shares of the technology company’s stock valued at $20,503,000 after purchasing an additional 28,953 shares during the period. Finally, Petrus Trust Company LTA acquired a new position in shares of Simulations Plus during the 3rd quarter worth approximately $682,000. 78.08% of the stock is owned by institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.